SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions announces the creation of a new business unit dedicated to helping customers bring new pharmaceutical and biologic products to market. The Development and Clinical Services segment brings together Catalent’s analytical and science services and regulatory consulting services, formerly in its Sterile Technologies segment, with its clinical supply services business, formerly included in the Packaging Services segment. Catalent also announces the appointment of Scott Houlton as Group President for the new segment, effective August 31st.
